Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Avagliano Insider Profile
4 Followers
Mark Avagliano, CBO at G1 Therapeutics, holds 0.00 shares in G1 Therapeutics (Ticker: GTHX).
Mark Avagliano has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Mark Avagliano does not currently own shares as a corporate insider.
A breakdown of Mark Avagliano's holdings
Insider Roles
Mark Avagliano does not currently hold a role as a corporate insider.
Roles that Mark Avagliano holds in companies
Most Profitable Insider Trade
Stock:
G1 Therapeutics
(GTHX)
(GTHX)
Rating:Informative Sell
Date:Jan 05, 2022 - Jan 05, 2023
Return:+48.70%
The most profitable trade made by Mark Avagliano
Mark Avagliano's Trading History
List of latest transactions for each holding click on a transaction to see Mark Avagliano's performance on stock
You May Also Like
Mark Avagliano insider profile FAQ
What is the percentage of profitable transactions made by Mark Avagliano?
The percentage of profitable transactions made by Mark Avagliano is ―.
What is the average return per transaction made by Mark Avagliano?
The average return per transaction made by Mark Avagliano is ―.
What stocks does Mark Avagliano hold?
Mark Avagliano holds: GTHX stocks.
What was Mark Avagliano’s latest transaction?
Mark Avagliano latest transaction was an Uninformative Buy of ―.
What was Mark Avagliano's most profitable transaction?
Mark Avagliano’s most profitable transaction was an Informative Sell of GTHX stock on January 5, 2022. The return on the trade was 48.70%.
What is Mark Avagliano's role in G1 Therapeutics?
Mark Avagliano's role in G1 Therapeutics is CBO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.